Study has shown that pyrimidine-based DAPK1/colony stimulating factor 1 receptor (CSF1R) dual inhibitor can significantly inhibit the proliferation of various tumor cell lines, including colon cancer cell line29. Here, CSF1R is linked to colonic neoplasm.